The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials
- 1 January 1994
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 21 (4), 646-655
- https://doi.org/10.1016/s0168-8278(94)80114-2
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier childrenThe Journal of Pediatrics, 1989
- A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive chinese childrenHepatology, 1988
- The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriersHepatology, 1987
- Altered natural history of hepatitis B in homosexual males–-a reflection of altered immune responsiveness?Journal of Medical Virology, 1985
- Hepatitis B Virus Dna, Hbeag and Delta Infection During the Course From Acute to Chronic Hepatitis B Virus InfectionHepatology, 1985
- Acute Dane Particle Suppression with Recombinant Leukocyte A Interferon in Chronic Hepatitis B Virus InfectionThe Journal of Infectious Diseases, 1983
- Persistent Infection of Humans with Hepatitis B Virus: Mechanisms and ConsequencesClinical Infectious Diseases, 1982
- Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B HepatitisAnnals of Internal Medicine, 1981
- Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine ArabinosideThe Journal of Infectious Diseases, 1981
- Dane Particles, DNA Polymerase, and e-Antigen in Two Different Categories of Hepatitis B Antigen CarriersIntervirology, 1975